VDR gene polymorphisms are associated with the clinical response to calcipotriol in psoriatic patients

J Dermatol Sci. 2015 Sep;79(3):305-7. doi: 10.1016/j.jdermsci.2015.06.014. Epub 2015 Jul 7.
No abstract available

Publication types

  • Letter
  • Research Support, Non-U.S. Gov't

MeSH terms

  • Acitretin / therapeutic use
  • Adult
  • Calcitriol / analogs & derivatives*
  • Calcitriol / therapeutic use
  • Calcium / blood
  • Dermatologic Agents / therapeutic use*
  • Drug Therapy, Combination
  • Female
  • Genotype
  • Humans
  • Keratolytic Agents / therapeutic use
  • Male
  • Middle Aged
  • Ointments / therapeutic use
  • Polymorphism, Single Nucleotide
  • Psoriasis / blood
  • Psoriasis / drug therapy*
  • Psoriasis / genetics*
  • Receptors, Calcitriol / genetics*
  • Severity of Illness Index

Substances

  • Dermatologic Agents
  • Keratolytic Agents
  • Ointments
  • Receptors, Calcitriol
  • VDR protein, human
  • calcipotriene
  • Calcitriol
  • Acitretin
  • Calcium